adamantane has been researched along with cardiovascular agents in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Foks, H; Kuźmierkiewicz, W; Saczewski, F | 1 |
| Campbell, WB; Falck, JR; Gauthier, KM; Gross, GJ; Hammock, BD; Moore, J; Nithipatikom, K | 1 |
2 other study(ies) available for adamantane and cardiovascular agents
| Article | Year |
|---|---|
Syntheses and biological activities of 2-(adamantylmethyl)benzimidazoles and -imidazolines.
Topics: Adamantane; Animals; Antitubercular Agents; Benzimidazoles; Cardiovascular Agents; Hemodynamics; Imidazoles; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Mycobacterium tuberculosis; Rats; Rats, Inbred Strains | 1986 |
Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart.
Topics: 8,11,14-Eicosatrienoic Acid; Adamantane; Animals; Blood Pressure; Cardiovascular Agents; Coronary Circulation; Diazoxide; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epoxide Hydrolases; Female; Heart Rate; Lauric Acids; Male; Mitochondria, Heart; Myocardial Infarction; Myocardium; Potassium Channels | 2008 |